These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7098495)

  • 1. A simple method for screening monoamine oxidase (MAO) inhibitory drugs for type preference.
    Dorris RL
    J Pharmacol Methods; 1982 Mar; 7(2):133-7. PubMed ID: 7098495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of type A monoamine oxidase by coptisine in mouse brain.
    Ro JS; Lee SS; Lee KS; Lee MK
    Life Sci; 2001 Dec; 70(6):639-45. PubMed ID: 11833714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S; Nahrstedt H; Panten U
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat and human cardiac monoamine oxidase: a comparison with other tissues.
    Dial EJ; Clarke DE
    Eur J Pharmacol; 1979 Oct; 58(3):313-9. PubMed ID: 510362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of ethaverine, a homologue of papaverine, on monoamine oxidase activity in mouse brain.
    Lee SS; Lee JJ; Cheong MJ; Kim YH; Kim Y; Yun YP; Lee CK; Lee MK
    Biol Pharm Bull; 2001 Jul; 24(7):838-40. PubMed ID: 11456127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations on the monamine oxidase activity of rat vasa deferentia, major blood vessels and human saphenous vein.
    Dial EJ; Clarke DE
    Res Commun Chem Pathol Pharmacol; 1977 May; 17(1):145-56. PubMed ID: 877399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,4-Benzoquinone as a new inhibitor of monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    Neurosci Lett; 1987 Jun; 77(2):215-20. PubMed ID: 3601232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay.
    Guang HM; Du GH
    Acta Pharmacol Sin; 2006 Jun; 27(6):760-6. PubMed ID: 16723097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinoline and quninaldine as naturally occurring inhibitors specific for type A monoamine oxidase.
    Naoi M; Nagatsu T
    Life Sci; 1987 Mar; 40(11):1075-82. PubMed ID: 3821373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-(O-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(O-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    J Neurochem; 1988 Jan; 50(1):243-7. PubMed ID: 3335842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aluminium (Al) on brain mitochondrial monoamine oxidase-A (MAO-A) activity--an in vitro kinetic study.
    Rao KS; Rao GV
    Mol Cell Biochem; 1994 Aug; 137(1):57-60. PubMed ID: 7845378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential localization of monoamine oxidase type A activity in neurons of the locus coeruleus and type B activity in neurons of the dorsal raphe nucleus of the rat: a detailed enzyme histochemical study.
    Arai R; Kimura H; Nagatsu I; Maeda T
    Brain Res; 1997 Jan; 745(1-2):352-6. PubMed ID: 9037433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of 1-Aminobenzotriazole and Ketoconazole as Novel Inhibitors of Monoamine Oxidase (MAO): An In Vitro Investigation.
    Shaik AN; LeDuc BW; Khan AA
    Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):827-834. PubMed ID: 28185143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of monoamine oxidase in monkey heart.
    Katayama M; Kobayashi S; Oguchi K; Yasuhara H
    Jpn J Pharmacol; 1984 Aug; 35(4):425-31. PubMed ID: 6438377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice.
    Fuller RW; Wong CJ; Hemrick-Luecke SK
    Life Sci; 1986 Feb; 38(5):409-12. PubMed ID: 3945167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of monoamine oxidase (MAO) enzymatic activity by high-performance liquid chromatography-diode array detection combined with an assay of oxidation with a peroxidase and its application to MAO inhibitors from foods and plants.
    Herraiz T; Flores A; Fernández L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():136-144. PubMed ID: 29268246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
    Gerardy J
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):793-802. PubMed ID: 7938567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of serotonin oxidation as a component of the altered substrate specificity in the Y444F mutant of recombinant human liver MAO A.
    Nandigama RK; Miller JR; Edmondson DE
    Biochemistry; 2001 Dec; 40(49):14839-46. PubMed ID: 11732903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.